Ryosuke Tonozuka

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Background and study aims: The two routes of EUS-guided biliary drainage(EUS-BD) are trans-luminal(TL) (choledocho-duodenostomy(CDS) and hepatico-gastrostomy(HGS)) and trans-papillary(TP) via an antegrade approach(AG). It is unclear whether TP or TL drainage should be preferred. We conducted a multicenter randomized study to compare the two routes. Patients and Methods: In this open label randomized study from 5 tertiary care centers, patients with unresectable malignant biliary obstruction and failed ERCP were randomized into receiving either EUS-guided transluminal (CDS or HGS) or transpapillary stenting (AG). Primary outcome was stent patency (recurrent biliary obstruction), assessed at 1,3,6, and 12 months. Analysis was done on per protocol basis. Results: 120 patients (67 males) were recruited from November 2021 to March 2024. There were 60 patients each in the TL (24CDS,36HGS) and TP arm. Median time to recurrent biliary obstruction was 294 days (95%CI 257.95 – 330.04) for TP group and 219 days (95% CI 122.45- 315.54) for TL group (p=0.03). At three months, 11 stents (20.37%) blocked in the TL group compared to three (5.77%) in the TP group (OR=0.24, 0.06-0.91, p=0.04). At six months, 21 (38.89%) stents blocked in the TL arm compared to 11 (21.15%) in the TP arm (OR=0.42, 0.17-0.99. P=0.04). There were 13 (21.66%) adverse events in the TL group (one death), and 8 (13.33%) in the TP group (OR=0.57,0.21-1.46. P=0.33). Conclusion: EUS-BD via TP route achieved longer stent patency and lower rate of recurrent biliary obstruction at 3 and 6 months compared to TL route.

Year:

2025

Endoscopic intraductal radiofrequency ablation (ID‐RFA) can curatively treat residual intraductal lesions after endoscopic papillectomy. This study aimed to verify the tissue invasiveness of ID‐RFA using a novel RF generator and to explore its appropriate settings in an animal experiment, followed by a small clinical study. Pig liver specimens were ablated using a dedicated RF catheter and two RF generators to investigate structural differences between them and the ablation effects produced under various voltage and power settings. Appropriate settings for the novel generator were sought to provide an ablation effect equivalent to that with the recommended settings for a conventional generator. The ablation effect was also observed at various ablation times in vitro. Then we performed ID‐RFA in five patients. Each generator has a different structure, and no novel generator settings are identical to the recommended conventional generator settings. Obtaining adequate ablation requires both sufficient power and sufficient voltage. Based on the validation experiments, we concluded that the appropriate novel generator settings were 125 Vp and 30 W for 30 s. In the clinical study, good tumor ablation was obtained with no recurrence after a single ID‐RFA treatment, although the incidence of ductal stricture was relatively high. ID‐RFA for residual intraductal lesions may potentially be curative. However, excessive ablation should be avoided. To ensure safe and effective ID‐RFA, a thorough understanding of the RF generator specifications is required.

Year:

2025

Background Endoscopic ultrasound‐guided tissue acquisition is vital for diagnosing pancreatic and peridigestive tract lesions. A new three‐prong asymmetry tip needle has been developed for this procedure. In this study, we retrospectively assessed the diagnostic ability, tissue collection volume, and procedural adverse events of the three‐prong asymmetry tip needle for solid pancreatic, subepithelial, and other organ lesions. Methods We analyzed the data of 58 consecutive patients who underwent endoscopic ultrasound‐guided tissue acquisition using a three‐prong asymmetry tip needle between August 2022 and April 2023 at a single care center. Results The tissue collection rate was 91.4% with 89.7% accuracy, 89.3% sensitivity, 100% specificity, 100% positive predictive value, and 25% negative predictive value. No significant differences in collection rates or diagnostic performance were observed based on the target organ, puncture route, or lesion size. Using our original assessment method, the average histological core tissue score was 3.1 ± 0.8, whereas the blood contamination volume was 2.5 ± 0.8. Only one of 58 patients (1.7%) developed a pancreatic fistula of moderate severity as an adverse event. Conclusions The three‐prong asymmetry tip needle demonstrated good diagnostic capability and adequate sample volume with safety for pancreatic, subepithelial, and other organ lesions.

Year:

2024

Background/Purpose Afferent loop syndrome (ALS) is a rare adverse event after gastrointestinal surgery requiring appropriate early decompression treatment. Several endoscopic interventions have been attempted for treatment, including endoscopic enteral metal stent placement (EMSP), endoscopic ultrasound (EUS)‐guided entero‐enterostomy (EUS‐EE), and EUS‐guided hepaticogastrostomy (EUS‐HGS). However, there are limited data on outcomes, including duration of stent patency. In this study, we evaluated the usefulness of each endoscopic intervention for malignant ALS. Methods We retrospectively investigated nine patients with malignant ALS who underwent EMSP, EUS‐EE, or EUS‐HGS. Information on technical success, clinical efficacy, adverse events, stent dysfunction, and overall survival was collected and analyzed. Results The most common symptoms were abdominal pain and cholangitis. ALS was treated by EMSP in three patients, EUS‐EE in three patients, and EUS‐HGS in three patients. Stent placement was successful and clinically effective in all patients with no adverse events. During follow‐up, stent dysfunction occurred in two patients treated by EUS‐HGS. Eight patients died of primary disease during a median follow‐up of 157 days. Conclusions Each of the available endoscopic interventions for malignant ALS can be expected to produce similar outcomes, including duration of stent patency. The choice of endoscopic intervention should be made based on the characteristics of each treatment.

Year:

2023

Collaborators (4)

Shuntaro Mukai

-

JAPAN
View details

Kento Shionoya

Tokyo Medical and Dental University

JAPAN
View details

Kenjiro Yamamoto

-

JAPAN
View details

Takao Itoi

-

JAPAN
View details